These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 6521666

  • 1. Dengue type 2 virus infection in human peripheral blood monocyte cultures.
    Hotta H, Wiharta AS, Hotta S, Homma M.
    Microbiol Immunol; 1984; 28(10):1099-109. PubMed ID: 6521666
    [Abstract] [Full Text] [Related]

  • 2. Antibody-mediated enhancement of dengue virus infection in mouse macrophage cell lines, Mk1 and Mm1.
    Hotta H, Wiharta AS, Hotta S.
    Proc Soc Exp Biol Med; 1984 Mar; 175(3):320-7. PubMed ID: 6364153
    [Abstract] [Full Text] [Related]

  • 3. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.
    Halstead SB, O'Rourke EJ.
    J Exp Med; 1977 Jul 01; 146(1):201-17. PubMed ID: 406347
    [Abstract] [Full Text] [Related]

  • 4. Absence of leukocytes permissive to dengue 2 virus in the acute phase of dengue hemorrhagic fever.
    Marchette NJ, O'Rourke T, Scott RM, Nimmannitya S, Halstead SB, Bancroft WH.
    Am J Trop Med Hyg; 1979 May 01; 28(3):570-6. PubMed ID: 453450
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of dengue virus infection in monocytes by flavivirus antisera.
    Halstead SB, Porterfield JS, O'Rourke EJ.
    Am J Trop Med Hyg; 1980 Jul 01; 29(4):638-42. PubMed ID: 6157332
    [Abstract] [Full Text] [Related]

  • 6. Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection.
    Halstead SB, O'Rourke EJ, Allison AC.
    J Exp Med; 1977 Jul 01; 146(1):218-29. PubMed ID: 195000
    [Abstract] [Full Text] [Related]

  • 7. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody.
    Halstead SB.
    J Infect Dis; 1979 Oct 01; 140(4):527-33. PubMed ID: 117061
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
    Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH.
    J Infect Dis; 2004 Mar 15; 189(6):990-1000. PubMed ID: 14999601
    [Abstract] [Full Text] [Related]

  • 13. Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes.
    Brandt WE, McCown JM, Top FH, Bancroft WH, Russell PK.
    Infect Immun; 1979 Nov 15; 26(2):534-41. PubMed ID: 121109
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes.
    Kou Z, Lim JY, Beltramello M, Quinn M, Chen H, Liu S, Martinez-Sobrido L, Diamond MS, Schlesinger JJ, de Silva A, Sallusto F, Jin X.
    Virology; 2011 Feb 05; 410(1):240-7. PubMed ID: 21131015
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype.
    Zivny J, DeFronzo M, Jarry W, Jameson J, Cruz J, Ennis FA, Rothman AL.
    J Immunol; 1999 Sep 01; 163(5):2754-60. PubMed ID: 10453018
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.